Dr. Michael Lee Kochman, MD

Dr. Kochman practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kochman's NPI, 1164438883, was assigned on August 1, 2006. Dr. Kochman holds Pennsylvania license MD049908L.

Dr. Kochman's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kochman's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Kochman is also affiliated with Chester County Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kochman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kochman practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kochman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kochman is licensed in Pennsylvania.

CMS data shows 371 Medicare services from Dr. Kochman across 11 procedure codes in 2024, for 282 Medicare patients. Medicare paid $51,584 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 282 Medicare patients who saw Dr. Kochman in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kochman's median patient age at 69, with 56% women.

In 2024, Dr. Kochman wrote 143 Medicare Part D claims for 44 patients. 90% of them were for generic drugs. CMS names the drug for 109 of them, across 5 drugs with 11 or more claims each, at $10,480 in total drug cost. In 2023, CMS named 115 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kochman for performance year 2024, reported as part of a group. Dr. Kochman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 509 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kochman, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 59 papers to Dr. Kochman, published from 2015 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Cholangiopancreatography, Endoscopic Retrograde, Colonoscopy and Pancreatitis. Dr. Kochman has published most often in Clin Gastroenterol Hepatol. Dr. Kochman's most frequent co-authors are Nuzhat Aziz Ahmad, MD, Vinay Chandrasekhara, MD and Gregory G. Ginsberg, MD.

CMS Open Payments shows 279 general payments to Dr. Kochman from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Intercept Pharmaceuticals, Inc. paid the most, $161,147. It also lists 12 research payments totaling $40,058 from 2023 to 2025.